Cargando…
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor
PURPOSE: Glycogen synthase kinase 3 (GSK3) is a key controlling element of many cellular processes including cell-cycle progression and recent studies suggest that GSK3 is a potential anticancer target. Changes in glucose metabolism associated with GSK3 inhibition may impact on lipid synthesis, whil...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424927/ https://www.ncbi.nlm.nih.gov/pubmed/30446846 http://dx.doi.org/10.1007/s10334-018-0719-3 |